BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 16971503)

  • 1. Estradiol protects against ethanol-induced bone loss by inhibiting up-regulation of receptor activator of nuclear factor-kappaB ligand in osteoblasts.
    Chen JR; Haley RL; Hidestrand M; Shankar K; Liu X; Lumpkin CK; Simpson PM; Badger TM; Ronis MJ
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1182-90. PubMed ID: 16971503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of estradiol on ethanol-induced bone loss involve inhibition of reactive oxygen species generation in osteoblasts and downstream activation of the extracellular signal-regulated kinase/signal transducer and activator of transcription 3/receptor activator of nuclear factor-kappaB ligand signaling cascade.
    Chen JR; Shankar K; Nagarajan S; Badger TM; Ronis MJ
    J Pharmacol Exp Ther; 2008 Jan; 324(1):50-9. PubMed ID: 17916759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway.
    Tsai HY; Lin HY; Fong YC; Wu JB; Chen YF; Tsuzuki M; Tang CH
    Eur J Pharmacol; 2008 Jun; 588(1):124-33. PubMed ID: 18495114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of Stewartia koreana on osteoclast differentiation and bone resorption.
    Park CK; Kim HJ; Kwak HB; Lee TH; Bang MH; Kim CM; Lee Y; Chung DK; Baek NI; Kim J; Lee ZH; Kim HH
    Int Immunopharmacol; 2007 Dec; 7(12):1507-16. PubMed ID: 17920527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluid flow induces Rankl expression in primary murine calvarial osteoblasts.
    Mehrotra M; Saegusa M; Wadhwa S; Voznesensky O; Peterson D; Pilbeam C
    J Cell Biochem; 2006 Aug; 98(5):1271-83. PubMed ID: 16514640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
    Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
    Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process.
    Mori K; Le Goff B; Charrier C; Battaglia S; Heymann D; Rédini F
    Bone; 2007 Apr; 40(4):981-90. PubMed ID: 17196895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the maturation of osteoblasts and osteoclastogenesis by glutamate.
    Lin TH; Yang RS; Tang CH; Wu MY; Fu WM
    Eur J Pharmacol; 2008 Jul; 589(1-3):37-44. PubMed ID: 18538763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic alcohol consumption during male rat adolescence impairs skeletal development through effects on osteoblast gene expression, bone mineral density, and bone strength.
    Wezeman FH; Emanuele MA; Emanuele NV; Moskal SF; Woods M; Suri M; Steiner J; LaPaglia N
    Alcohol Clin Exp Res; 1999 Sep; 23(9):1534-42. PubMed ID: 10512321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gu Ling Pian, a traditional Chinese medicine, regulates function and OPG/RANKL synthesis of osteoblasts via the p38 MAPK pathway.
    Zhao Y; Li J; Liu Y; Yu KQ; Zhang J; Chen XG
    J Pharm Pharmacol; 2007 Aug; 59(8):1167-73. PubMed ID: 17725861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloroform extract of deer antler inhibits osteoclast differentiation and bone resorption.
    Li YJ; Kim TH; Kwak HB; Lee ZH; Lee SY; Jhon GJ
    J Ethnopharmacol; 2007 Sep; 113(2):191-8. PubMed ID: 17646068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
    Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
    Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
    Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
    Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic ethanol consumption inhibits postlactational anabolic bone rebuilding in female rats.
    Shankar K; Hidestrand M; Liu X; Chen JR; Haley R; Perrien DS; Skinner RA; Lumpkin CK; Badger TM; Ronis MJ
    J Bone Miner Res; 2008 Mar; 23(3):338-49. PubMed ID: 17967133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential mRNA expression profiles in proximal tibia of aged rats in response to ovariectomy and low-Ca diet.
    Zhang Y; Dong XL; Leung PC; Wong MS
    Bone; 2009 Jan; 44(1):46-52. PubMed ID: 18848653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regulation of receptor activator of nuclear factor kappaB ligand and osteoprotegerin expression by prostaglandin E2 in osteoblastic-like cells].
    Wang BL; Zheng F; Qiu MC
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1992-6. PubMed ID: 19062743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
    Yi T; Lee HL; Cha JH; Ko SI; Kim HJ; Shin HI; Woo KM; Ryoo HM; Kim GS; Baek JH
    J Cell Physiol; 2008 Nov; 217(2):409-22. PubMed ID: 18543257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF-κB and ERK activation.
    Ang ES; Yang X; Chen H; Liu Q; Zheng MH; Xu J
    FEBS Lett; 2011 Sep; 585(17):2755-62. PubMed ID: 21835177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential activity of kaempferol and quercetin in attenuating tumor necrosis factor receptor family signaling in bone cells.
    Pang JL; Ricupero DA; Huang S; Fatma N; Singh DP; Romero JR; Chattopadhyay N
    Biochem Pharmacol; 2006 Mar; 71(6):818-26. PubMed ID: 16434028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel isoflavone derivatives inhibit RANKL-induced osteoclast formation.
    Tang CH; Chang CS; Tan TW; Liu SC; Liu JF
    Eur J Pharmacol; 2010 Dec; 648(1-3):59-66. PubMed ID: 20850430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.